preventive care cat veterinarian
What can we all, as cat owners or veterinarians, do to promote cat health? Click here to read about this subject and find out more information.
Search
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
COVID-19 Relief Efforts in China
Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
My.Making More Health Website
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
garbage game
Learn more about marine pollution and find out how long it takes for garbage to dissolve in the oceans.
What can the patient do?
Be aware and know your source.
Innovation, animal well-being and productivity
Boehringer Ingelheim reinforces its focus on innovation, animal well-being and productivity. Click here to learn and find out more information.
The Supplier Code of Conduct
Read about Boehringer Ingelheim's expectations towards its suppliers on ethical behaviour, integrity, professionalism and common business requirements.
Circular economy towards the future
Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”. Find out more here.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Ingelheim
The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. Click here to find out and learn more about our headquarters.
Partnering for innovation and growth
In this interview Dr Frerich de Vries talks about why partnerships are one of the key areas of interest for Boehringer Ingelheim and more. Learn more.
COVID-Relief-India-2021
Boehringer Ingelheim prioritises life continuity to the underserved, in addition to medical aid. Click here to find out and learn more information.
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Our Expectations
We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners. Click here to learn more.
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
CDSCO approves SPEVIGO® (spesolimab)
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.